Patents by Inventor Claude Cabos

Claude Cabos has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250101021
    Abstract: Disclosed herein are improved synthetic routes for making (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1 H-imidazo[4,5-c]pyridin-2(3H)-one (tolebrutinbib). Also disclosed herein are novel compounds used in the synthesis of of (R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1 H-imidazo[4,5-c]pyridin-2(3H)-one.
    Type: Application
    Filed: December 11, 2024
    Publication date: March 27, 2025
    Applicant: Principia Biopharma Inc.
    Inventors: Frédéric Bailly, Christophe Benelli, Cyril Borie, Michaël Bosch, Claude Cabos, Alexis Charaudeau, Laurence Janssens, François Pacquet, Fabien Rodier, Laurent Sallé, Alfred Sodo, Sylvie Vigne
  • Patent number: 7378521
    Abstract: The invention relates to a process for the preparation of substituted 2-vinyl-2-arylmorpholine derivatives as described herein. This invention also relates to 2-vinyl-2-arylmorpholine derivatives as well as intermediates therefor.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: May 27, 2008
    Assignee: Sanofi-Aventis
    Inventors: Alain Aulombard, Francoise Bernon, Alain Burgos, Claude Cabos, Eric Lucas, Sabrina Bonnefoy
  • Publication number: 20070167623
    Abstract: The invention relates to a process for the preparation of substituted 2-vinyl-2-arylmorpholine derivatives as described herein. This invention also relates to 2-vinyl-2-arylmorpholine derivatives as well as intermediates therefor.
    Type: Application
    Filed: March 29, 2007
    Publication date: July 19, 2007
    Applicant: SANOFI-AVENTIS
    Inventors: Alain AULOMBARD, Francoise BERNON, Sabrina BONNEFOY, Alain BURGOS, Claude CABOS, Eric LUCAS
  • Patent number: 7223860
    Abstract: The invention relates to a process for the preparation of substituted 2-vinyl-2-arylmorpholine derivatives as described herein. This invention also relates to 2-vinyl-2-arylmorpholine derivatives as well as intermediates therefor.
    Type: Grant
    Filed: March 8, 2006
    Date of Patent: May 29, 2007
    Assignee: Sanofi-Aventis
    Inventors: Alain Aulombard, Francoise Bernon, Alain Burgos, Claude Cabos, Eric Lucas, Sabrina Bonnefoy
  • Publication number: 20060149058
    Abstract: The invention relates to a process for the preparation of substituted 2-vinyl-2-arylmorpholine derivatives as described herein. This invention also relates to 2-vinyl-2-arylmorpholine derivatives as well as intermediates therefor.
    Type: Application
    Filed: March 8, 2006
    Publication date: July 6, 2006
    Applicant: sanofi-aventis
    Inventors: Alain Aulombard, Francoise Bernon, Sabrina Bonnefoy, Alain Burgos, Claude Cabos, Erice Lucas
  • Patent number: 7038044
    Abstract: The invention relates to a process for the preparation of substituted 2-(2-arylmorpholin-2-yl)ethanol derivatives.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: May 2, 2006
    Assignee: sanofi-aventis
    Inventors: Alain Aulombard, Françoise Bernon, Sabrina Bonnefoy, Alain Burgos, Claude Cabos, Eric Lucas
  • Patent number: 6392039
    Abstract: The invention relates to a process for preparing (R)-(+)-3-{1-[2-(4-benzoyl-2-(3,4-difluorophenyl)-morpholin-2-yl)ethyl]-4-phenylpiperid-4-yl}-1,1-dimethylurea and the salts, solvates and/or hydrates thereof.
    Type: Grant
    Filed: June 19, 2001
    Date of Patent: May 21, 2002
    Assignee: Sanofi-Synthelabo
    Inventors: Alain Aulombard, Francoise Bernon, Sabrina Bonnefoy, Alain Burgos, Claude Cabos, Eric Lucas